Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Ambrogio Fassina"'
Autor:
Akihiko Kawahara, Jun Akiba, Hirohisa Yano, Ambrogio Fassina, Rocco Cappellesso, Yoshiki Naito, Maria Guido, Paolo Simioni, Giuliana Cortese, Lorenzo Nicolè, Tiziana Sanavia, Valeria Maffeis, Claudia Maria Radu, Davide Serafin, Giacomo Zanus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background Hepatocellular carcinoma (HCC) is a highly lethal cancer and the second leading cause of cancer-related deaths worldwide. As demonstrated in other solid neoplasms and HCC, infiltrating CD8+ T cells seem to be related to a better prognosis,
Externí odkaz:
https://doaj.org/article/0a285e23f19c4f498713d63cb388c4d4
Autor:
Lorenzo Nicolè, Filippo Cappello, Rocco Cappellesso, Luisa Piccin, Laura Ventura, Vincenza Guzzardo, Paolo Del Fiore, Vanna Chiarion-Sileni, Angelo Paolo Dei Tos, Simone Mocellin, Ambrogio Fassina
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Malignant melanoma (MM) is the most lethal skin cancer. AXL is a tyrosine kinase receptor involved in several oncogenic processes and might play a role in blocking necroptosis (a regulated cell death mechanism) in MM through the downregulation of the
Externí odkaz:
https://doaj.org/article/9679d8a719344eb2a6d4c19e2fd12cec
Autor:
Matteo Bulloni, Giada Sandrini, Irene Stacchiotti, Massimo Barberis, Fiorella Calabrese, Lina Carvalho, Gabriella Fontanini, Greta Alì, Francesco Fortarezza, Paul Hofman, Veronique Hofman, Izidor Kern, Eugenio Maiorano, Roberta Maragliano, Deborah Marchiori, Jasna Metovic, Mauro Papotti, Federica Pezzuto, Eleonora Pisa, Myriam Remmelink, Gabriella Serio, Andrea Marzullo, Senia Maria Rosaria Trabucco, Antonio Pennella, Angela De Palma, Giuseppe Marulli, Ambrogio Fassina, Valeria Maffeis, Gabriella Nesi, Salma Naheed, Federico Rea, Christian H. Ottensmeier, Fausto Sessa, Silvia Uccella, Giuseppe Pelosi, Linda Pattini
Publikováno v:
Cancers, Vol 13, Iss 19, p 4875 (2021)
Lung neuroendocrine neoplasms (lung NENs) are categorised by morphology, defining a classification sometimes unable to reflect ultimate clinical outcome. Subjectivity and poor reproducibility characterise diagnosis and prognosis assessment of all NEN
Externí odkaz:
https://doaj.org/article/df1b7bf572d940139246eba37716c7c6
Autor:
Leonardo Franz, Lorenzo Nicolè, Anna Chiara Frigo, Giancarlo Ottaviano, Piergiorgio Gaudioso, Tommaso Saccardo, Francesca Visconti, Rocco Cappellesso, Stella Blandamura, Ambrogio Fassina, Gino Marioni
Publikováno v:
Cancers, Vol 13, Iss 13, p 3339 (2021)
The mechanism of epithelial–mesenchymal transition (EMT) is fundamental for carcinogenesis, tumor progression, cancer cell invasion, metastasis, recurrence, and therapy resistance, comprising important events, such as cellular junction degradation,
Externí odkaz:
https://doaj.org/article/64ced50694964aa194fb5f15d09a44e4
Autor:
Simona Censi, Elisabetta Cavedon, Loris Bertazza, Francesca Galuppini, Sara Watutantrige-Fernando, Paola De Lazzari, Davide Nacamulli, Gianmaria Pennelli, Ambrogio Fassina, Maurizio Iacobone, Eric Casal Ide, Federica Vianello, Susi Barollo, Caterina Mian
Publikováno v:
Frontiers in Endocrinology, Vol 8 (2017)
PurposeThe management of thyroid nodules of indeterminate cytology is controversial. Our study aimed to establish the frequency and significance of H-,K-,N-RAS, TERT promoter, and BRAF gene mutations in thyroid nodes of indeterminate cytology and to
Externí odkaz:
https://doaj.org/article/f684f11276d944c79fbfa5ed3687423d
Autor:
Susi Barollo, Loris Bertazza, Sara Watutantrige-Fernando, Simona Censi, Elisabetta Cavedon, Francesca Galuppini, Gianmaria Pennelli, Ambrogio Fassina, Marilisa Citton, Beatrice Rubin, Raffaele Pezzani, Clara Benna, Giuseppe Opocher, Maurizio Iacobone, Caterina Mian
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156044 (2016)
BACKGROUND:6-18F-fluoro-L-3,4-dihydroxyphenylalanine (18F-FDOPA) PET is a useful tool in the clinical management of pheochromocytoma (PHEO) and medullary thyroid carcinoma (MTC). 18F-FDOPA is a large neutral amino acid biochemically resembling endoge
Externí odkaz:
https://doaj.org/article/f98a91ec3a5b42ccad1b15bf273645f7
Autor:
Catia Pilon, Andrea Rebellato, Riccardo Urbanet, Vincenza Guzzardo, Rocco Cappellesso, Hironobu Sasano, Ambrogio Fassina, Francesco Fallo
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
We previously showed a decreased expression of vitamin D receptor (VDR) mRNA/protein in a small group of adrenocortical carcinoma (ACC) tissues, suggesting the loss of a protective role of VDR against malignant cell growth in this cancer type. Downre
Externí odkaz:
https://doaj.org/article/9a33cb739b974a2090f96d29d1bc8afe
Autor:
Rocco Cappellesso, Renato Millioni, Giorgio Arrigoni, Francesca Simonato, Brasilina Caroccia, Elisabetta Iori, Vincenza Guzzardo, Laura Ventura, Paolo Tessari, Ambrogio Fassina
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126458 (2015)
Adenocarcinoma (AdC) is the most common lung cancer subtype and is often associated with pleural effusion (PE). Its poor prognosis is attributable to diagnostic delay and lack of effective treatments and there is a pressing need in discovering new bi
Externí odkaz:
https://doaj.org/article/b190e30f82fc490680e9ebc9cd0158f1
Autor:
Francesca Simonato, Laura Ventura, Nicola Sartori, Rocco Cappellesso, Matteo Fassan, Lill-Tove Busund, Ambrogio Fassina
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57490 (2013)
MicroRNAs' dysregulation and profiling have been demonstrated to be clinically relevant in urothelial carcinoma (UC). Urine cytology is commonly used as the mainstay non-invasive test for secondary prevention and follow-up of UC patients. Ancillary t
Externí odkaz:
https://doaj.org/article/1dc93f8f621b4592a76e8a12886c186e
Autor:
Aldo Scarpa, Katarzyna Sikora, Matteo Fassan, Anna Maria Rachiglio, Rocco Cappellesso, Davide Antonello, Eliana Amato, Andrea Mafficini, Matilde Lambiase, Claudia Esposito, Emilio Bria, Francesca Simonato, Maria Scardoni, Giona Turri, Marco Chilosi, Giampaolo Tortora, Ambrogio Fassina, Nicola Normanno
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80478 (2013)
Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents that are already approved for clinical use or are in clinical trials. Therefore, the number of biomarkers that will be needed to assess is expected to
Externí odkaz:
https://doaj.org/article/042dba26cd71478e84302bbe0f5d9039